Sho Uehara

788 total citations
60 papers, 493 citations indexed

About

Sho Uehara is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Physiology. According to data from OpenAlex, Sho Uehara has authored 60 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 26 papers in Surgery and 12 papers in Physiology. Recurrent topics in Sho Uehara's work include Bladder and Urothelial Cancer Treatments (19 papers), Renal cell carcinoma treatment (12 papers) and Urinary and Genital Oncology Studies (12 papers). Sho Uehara is often cited by papers focused on Bladder and Urothelial Cancer Treatments (19 papers), Renal cell carcinoma treatment (12 papers) and Urinary and Genital Oncology Studies (12 papers). Sho Uehara collaborates with scholars based in Japan and United States. Sho Uehara's co-authors include Yasuhisa Fujii, Yoh Matsuoka, Minato Yokoyama, Soichiro Yoshida, Yosuke Yasuda, Kazutaka Saito, Hajime Tanaka, Junichiro Ishioka, Toshiki Kijima and Kazunori Kihara and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of The Electrochemical Society and Radiology.

In The Last Decade

Sho Uehara

55 papers receiving 484 citations

Peers

Countries citing papers authored by Sho Uehara

Since Specialization

Citations

This map shows the geographic impact of Sho Uehara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Uehara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Uehara more than expected).

Fields of papers citing papers by Sho Uehara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Uehara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Uehara. The network helps show where Sho Uehara may publish in the future.

Co-authorship network of co-authors of Sho Uehara

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Uehara. A scholar is included among the top collaborators of Sho Uehara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Uehara. Sho Uehara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study 2024 ·International Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takanobu Yamamoto, Sho Uehara, (unknown), Masaharu Inoue, Ryoji Takazawa, Noboru Numao, (unknown), Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii	2
2	Outcomes and prognostic factors in patients with synchronous and metachronous oligometastatic urothelial carcinoma with visceral metastases 2024 ·International Journal of Urology ·Soichiro Yoshida, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Takanobu Yamamoto, Sho Uehara, (unknown), Masaharu Inoue, Ryoji Takazawa, Noboru Numao, (unknown), Hajime Tanaka, Yasuhisa Fujii	2
3	Utility of positive core number on MRI‐ultrasound fusion targeted biopsy in combination with PI‐RADS scores for predicting unexpected extracapsular extension of clinically localized prostate cancer 2024 ·International Journal of Urology ·Masaki Kobayashi, Yoh Matsuoka, Sho Uehara, Hiroshi Tanaka, (unknown), Yuki Nakamura, (unknown), Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Soichiro Yoshida, Yasuhisa Fujii	2
4	The role of multimodal salvage therapy in the management of recurrent adrenocortical carcinoma 2023 ·Japanese Journal of Clinical Oncology ·Toshiki Kijima, Shohei Fukuda, Hiroshi Fukushima, Sho Uehara, Yosuke Yasuda, (unknown), (unknown), Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii	0
5	Defining Tumour Shape Irregularity for Preoperative Risk Stratification of Clinically Localised Renal Cell Carcinoma 2022 ·European Urology Open Science ·Hajime Tanaka, Shohei Fukuda, Koichiro Kimura, (unknown), Kouhei Yamamoto, Hiroshi Fukushima, Shingo Moriyama, Yosuke Yasuda, Sho Uehara, Yuma Waseda, Soichiro Yoshida, Minato Yokoyama, Yoh Matsuoka, Kazutaka Saito, Ukihide Tateishi, Steven C. Campbell, Yasuhisa Fujii	3
6	Antineutrophil cytoplasmic antibody-negative granulomatosis with polyangiitis localized to the lungs 2022 ·Respiratory Medicine Case Reports ·(unknown), Kazuki Hamada, Keiji Oishi, (unknown), Misa Harada, (unknown), (unknown), Kazuki Matsuda, Sho Uehara, (unknown), Yoriyuki Murata, Yoshikazu Yamaji, Kenji Sakamoto, Maki Asami‐Noyama, Nobutaka Edakuni, Tsunahiko Hirano, Tomoyuki Kakugawa, Tomoyuki Murakami, Tamiko Takemura, Kazuto Matsunaga	1
7	Abundant TNF-LIGHT expression in the airways of patients with asthma with persistent airflow limitation: Association with nitrative and inflammatory profiles 2021 ·Respiratory Investigation ·Tsunahiko Hirano, Kazuto Matsunaga, Keiji Oishi, Keiko Doi, Misa Harada, (unknown), (unknown), (unknown), (unknown), Kazuki Matsuda, Sho Uehara, Kazuki Hamada, (unknown), Yoriyuki Murata, Yoshikazu Yamaji, Maki Asami‐Noyama, Nobutaka Edakuni	7
8	Application of virtual reality in patient education about MRI-ultrasound fusion prostate biopsy 2020 ·European Urology Open Science ·(unknown), N. Taniguchi, Shingo Moriyama, Sho Uehara, H. Tanaka, Toshiki Kijima, M. Yokoyama, Junichiro Ishioka, Y. Matsuoka, Keisuke Saito, Yasuhisa Fujii	2
9	Significance of Bladder Neck Involvement in Risk Substratification of Intermediate-Risk Non–muscle-invasive Bladder Cancer 2020 ·European Urology Focus ·Hiroshi Fukushima, Shingo Moriyama, Yuma Waseda, Shohei Fukuda, Sho Uehara, Hajime Tanaka, Toshiki Kijima, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii	9
10	Value of extra‐target prostate biopsy for the detection of magnetic resonance imaging‐missed adverse pathology according to the Prostate Imaging Reporting and Data System scores: Spatial analysis using magnetic resonance–ultrasound fusion images 2020 ·International Journal of Urology ·Yoh Matsuoka, Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Kazutaka Saito, Yasuhisa Fujii	3
11	Combination of assist use of short-acting beta-2 agonists inhalation and guidance based on patient-specific restrictions in daily behavior: Impact on physical activity of Japanese patients with chronic obstructive pulmonary disease 2019 ·Respiratory Investigation ·Tsunahiko Hirano, Kazuto Matsunaga, Kazuki Hamada, Sho Uehara, (unknown), Yoshikazu Yamaji, Keiji Oishi, Maki Asami, Nobutaka Edakuni, Hiromasa Ogawa, Masakazu Ichinose	10
12	Cutaneous Vasculitis Induced by Osimertinib 2019 ·Journal of Thoracic Oncology ·Kazuki Hamada, Keiji Oishi, (unknown), (unknown), (unknown), (unknown), Kazuki Matsuda, Sho Uehara, (unknown), Yoshikazu Yamaji, Yoriyuki Murata, Maki Asami‐Noyama, Nobutaka Edakuni, Tsunahiko Hirano, Yutaka Shimomura, Kazuto Matsunaga	6
13	Cryptococcosis as a cause of organizing pneumonia 2019 ·Respiratory Medicine Case Reports ·(unknown), Keiji Oishi, Kazuki Hamada, Kazuki Matsuda, Sho Uehara, (unknown), Yoshikazu Yamaji, Maki Asami‐Noyama, Nobutaka Edakuni, Tsunahiko Hirano, Tomoyuki Murakami, Kazuto Matsunaga	6
14	Clinical Outcomes of Patients With Histologic Variants of Urothelial Carcinoma Treated With Selective Tetramodal Bladder-preservation Therapy Incorporating Consolidative Partial Cystectomy 2019 ·Clinical Genitourinary Cancer ·Toshiki Kijima, Hajime Tanaka, Sho Uehara, Soichiro Yoshida, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Kazunori Kihara, Yasuhisa Fujii	4
15	Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan 2018 ·International Journal of COPD ·Keiji Oishi, Tsunahiko Hirano, Kazuki Hamada, Sho Uehara, (unknown), Yoshikazu Yamaji, Kosuke Ito, Maki Asami‐Noyama, Nobutaka Edakuni, Kazuto Matsunaga	15
16	Early response of C-reactive protein as a predictor of survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors 2017 ·International Journal of Clinical Oncology ·Yosuke Yasuda, Kazutaka Saito, Takeshi Yuasa, Sho Uehara, Naoko Kawamura, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Shinya Yamamoto, Tetsuo Okuno, Junji Yonese, Kazunori Kihara, Yasuhisa Fujii	27
17	Prediction of Intraoperative Urinary Collecting System Entry in Patients with Peripheral Renal Tumors Undergoing Partial Nephrectomy: Usefulness of Tumor-Centered Multiplanar Reconstruction 2017 ·Urologia Internationalis ·Sho Uehara, Soichiro Yoshida, Hiroshi Tanaka, Yosuke Yasuda, Hajime Tanaka, Toshiki Kijima, Minato Yokoyama, Junichiro Ishioka, Yoh Matsuoka, Kazutaka Saito, Yasuhisa Fujii	2
18	Improvement of renal function by changing the bone-modifying agent from zoledronic acid to denosumab 2016 ·International Journal of Clinical Oncology ·Mutsushi Yamasaki, Takeshi Yuasa, Sho Uehara, Yasuhisa Fujii, Shinya Yamamoto, Hitoshi Masuda, Iwao Fukui, Junji Yonese	9
19	Long-term complete response of antiandrogen withdrawal syndrome in a patient with metastatic prostate cancer: A case report 2016 ·Molecular and Clinical Oncology ·Masayuki Sano, Shinya Yamamoto, Sho Uehara, Takeshi Yuasa, Hitoshi Masuda, Iwao Fukui, Junji Yonese	0
20	Primary non-Hodgkin lymphoma of the sinonasal cavities: correlation of CT evaluation with clinical outcome. 1997 ·Radiology ·Katsumasa Nakamura, Sho Uehara, Junichi Omagari, Naonobu Kunitake, Masahiko Kimura, Yasuhiro Makino, Junji Murakami, K Jingu, K. Masuda	34

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact